Endocannabinoid and Nitric Oxide-Dependent IGF-I-Mediated Synaptic Plasticity at Mice Barrel Cortex

Area of Science:

• Neuroscience
• Molecular Biology
• Synaptic Plasticity

Background:

• Insulin-like growth factor-I (IGF-I) signaling is crucial for learning and memory.
• IGF-I enhances neuronal excitability and synaptic plasticity in the mouse barrel cortex.
• The precise molecular mechanisms underlying IGF-I's neuromodulatory effects are not fully understood.

Purpose of the Study:

• To investigate the roles of endocannabinoids (eCBs) and nitric oxide (NO) in mediating IGF-I's effects on synaptic transmission.
• To determine whether eCBs and NO are necessary for IGF-I to modulate excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs).

Main Methods:

• Electrophysiological recordings of EPSCs and IPSCs in layer II/III pyramidal neurons of the mouse barrel cortex.
• Application of IGF-I alone and in combination with a cannabinoid receptor 1 (CB1R) antagonist (AM251) and a nitric oxide synthase inhibitor (L-NAME).

Main Results:

• Nitric oxide (NO) synthesis inhibition with L-NAME completely abolished IGF-I's modulatory effects on both excitatory and inhibitory transmission.
• Blocking cannabinoid receptor 1 (CB1R) with AM251 not only prevented IGF-I-induced potentiation of EPSCs but reversed it into depression.
• These findings indicate that NO is essential for IGF-I's actions, while eCBs play a critical role in determining the direction of synaptic plasticity.

Conclusions:

• Endocannabinoids (eCBs) and nitric oxide (NO) are vital signaling molecules that dictate the net effect of IGF-I on synaptic transmission in the neocortex.
• A complex neuromodulatory interplay exists among IGF-I, NO, and eCBs in regulating neural function.
• Understanding these interactions could offer new insights into cognitive processes and potential therapeutic targets.